HDAC I/IIb Selective Inhibitor Purinostat Mesylate in Relapsed and Refractory Diffuse Large B-cell Lymphoma: A Single Agent Phase IIa Trial.

Lijuan Chen,Linyu Yang,Jie Wang, Rui Liang,He Li,Mengke Liu, Yi Wen,Lin Liu,Xiaoqiong Tang, Jieping Li,Xun Lai, Huijing Wu,Yajun Li, Shihua Huang, Lihua Yang, Ke Tan,Li Wang,Ting Niu,Weili Zhao

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用 0|浏览6

暂无评分

关键词

283-224-3869-503-11719-7164,3282-3301-2800,3282-206-4924-4988-8935,3282-206-3691-2722-5055,298-145-222-184-1022-9124-9022,298-145-222-184-1022-9124-9020,298-145-222-8996,285,2455,1602,38092-34303,38092-22583

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要